Diabetes education to protect tomorrow
Prof Andrew Boulton, President, International Diabetes Federation, calls for more to be done to improve access to diabetes education.
Peripheral neuropathy: Tracking gait and biomarkers to keep feet healthy and whole
Novel smart insole solution helps people with diabetes ensure foot health, by preventing peripheral neuropathy ulcers and falls.
Unlocking life-changing dementia treatments
Is better diagnosis the key to unlocking life-changing dementia treatments? Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK provides the answer.
The global picture of Tuberculosis: A view from WHO
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
Tickborne diseases: A growing health problem in the U.S.
Chief of the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the Centers for Disease Control & Prevention, walks us through a growing health problem in the United States, tickborne diseases.
PAVE: Global research study on epidemiology of Alzheimer’s disease
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
The role optical practices play in dealing with eye problems
Daryl Newsome FBDO R CL SMC(Tech), President of the Association of British Dispensing Opticians, examines the important role that optical practices can play in dealing with eye problems.
Key to faster diagnosis for lung conditions in the NHS
Misdiagnoses and delays are far too common for people with lung conditions. Rachel Warren, Senior Policy Officer at Asthma + Lung UK and Policy Lead (Diagnosis) at the Taskforce for Lung Health, explores how new community diagnostic centres could help tackle this issue.
Reduce risk of dementia through leisure activities
Dementia poses a risk to us all, but research shows that there are leisure activities that are scientifically proven to reduce risk of dementia.
Unusual signs and symptoms of raised cholesterol
Many people only become aware for the first time that they have a high cholesterol level, only when they are admitted to hospital with a heart attack.
Lyme disease diagnoses increased 357% in rural areas
Lyme disease diagnoses have increased 357% in rural areas and 65% in urban areas in the United States, causing national concern.
Hair loss and low libido added as symptoms of COVID-19
Hair loss and sexual dysfunction, or low libido, have been added to the long list of symptoms of COVID-19 and those with long COVID.
COVID-19 symptoms are changing with new variants
A sore throat and hoarse voice were the main COVID-19 symptoms with newer variants – but have symptoms changed as variants get smarter?
Type 1 diabetes treatment finds new target
A new route to the regeneration of insulin in the pancreatic stem cells indicates a major breakthrough for Types 1 and 2 Diabetes therapies.
Diabetes education: one in five search results for diabetes lack reliable information
Improved, reliable diabetes education is needed for both people living with diabetes and healthcare professionals.
Omicron subvariants are better at eluding vaccines
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease
The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.
Disease X and other high priority diseases
According to the WHO, Disease X refers to a hypothetical, unknown pathogen that could cause a future epidemic.
Data capture for researching degenerative eye disease
Translational Imaging Innovations makes data accessible to research degenerative eye disease.
Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
